We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+25.03%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.13B
AUM Growth
-$243M
(-7.2%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-37.82%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
93
New
20
Increased
16
Reduced
29
Closed
16
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$55.4M |
| 2 |
Kodiak Sciences
KOD
|
+$42.4M |
| 3 |
BrightSpring Health Services
BTSG
|
+$40.1M |
| 4 |
Celldex Therapeutics
CLDX
|
+$33.4M |
| 5 |
Illumina
ILMN
|
+$31.7M |
Top Sells
| 1 |
Xenon Pharmaceuticals
XENE
|
+$74.8M |
| 2 |
Krystal Biotech
KRYS
|
+$67M |
| 3 |
CG Oncology
CGON
|
+$58.5M |
| 4 |
Apogee Therapeutics
APGE
|
+$54.4M |
| 5 |
Danaher
DHR
|
+$42M |
Sector Composition
| 1 | Healthcare | 83.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ultragenyx Pharmaceutical
RARE
$3.12B
| – | – |
-588,700
| Closed | -$17.7M |
|
77
Replimune Group
REPL
$813M
| – | – |
-2,750,092
| Closed | -$11.5M |
|
|
RNAM
78
DELISTED
Avidity Biosciences
RNAM
| – | – |
-331,907
| Closed | -$14.5M |
|
79
Royalty Pharma
RPRX
$25B
| – | – |
-182,068
| Closed | -$6.42M |
|
80
Sarepta Therapeutics
SRPT
$1.86B
| – | – |
-832,100
| Closed | -$16M |
|
81
Tenet Healthcare
THC
$16.6B
| – | – |
-121,700
| Closed | -$24.7M |
|
82
Viking Therapeutics
VKTX
$4.39B
| – | – |
-759,455
| Closed | -$20M |
|
|
SION
83
Sionna Therapeutics
SION
$2B
| – | – |
-314,013
| Closed | -$9.24M |
|
|
HTFL
84
Heartflow Inc
HTFL
$2.35B
| – | – |
-50,000
| Closed | -$1.68M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM